Xona already holds the exclusive license to manufacture its neuronal research devices in the US, and this new European patent adds to its exclusivity in Europe, specifically the United Kingdom, Ireland, Switzerland, France, Spain and Germany.
The patents are assigned to the University of California and licensed exclusively to Xona.
Dr. Anne Taylor, Assistant Professor at the University of North Carolina at Chapel Hill, invented the neuron device while working as a graduate student in the laboratory of Dr. Noo Li Jeon at the University of California, Irvine in 2003. Dr. Carl Cotman, Professor of Neuroscience at the University of California, Irvine, helped guide Dr. Taylor's research.
Dr. Taylor, Dr. Jeon and Dr. Cotman are all credited as co-inventors.
Xona Microfluidics is focused on manufacturing and distributing microfluidic devices to neuroscientists and laboratories worldwide. The company has offices in Temecula, California and Research Triangle Park in Durham, North Carolina.
Kazia Therapeutics doses first patient in paediatric AT/RT study
Fusion Antibodies secures Canadian patent for OptiMAL
Revvity to acquire Human Cell Design to expand metabolic disease drug discovery capabilities
Biophytis expands BIO101 obesity study to assess weight regain
THX Pharma secures European patent for Batten-1 in juvenile Batten disease
Orphalan commences Phase 3 study of trientine therapy in Wilson disease
ZAGENO named Frost & Sullivan's 2026 North American Life Sciences E-Commerce Company of the Year
Pharvaris reports Phase 3 success for deucrictibant XR in HAE prophylaxis
Sky Labs presents clinical research outcomes for ring-type blood pressure monitor CART
Etcamah–CDK4/6 inhibitor combination approved in US for ESR1-mutated HR-positive breast cancer
Ionis partner Novartis reports pelacarsen Phase 3 trial misses primary endpoint
Guardant Health wins FDA approval for Guardant360 CDx in advanced breast cancer
4basebio announces expansion of DNA offering for personalised mRNA medicines